ClinicalTrials.Veeva

Menu

Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis (GAMES)

R

Rennes University Hospital

Status

Completed

Conditions

Sarcoidosis

Treatments

Biological: Analysis of gamma globulin

Study type

Observational

Funder types

Other

Identifiers

NCT03259282
35RC16_3046_GAMES

Details and patient eligibility

About

Evaluation of the rate of achievement of serum protein electrophoresis (PPE) in diagnosis in a retrospective cohort of patients at Rennes University Hospital

Full description

In 50% of cases, sarcoidosis is associated with polyclonal hypergammaglobulinemia. The other forms have a normal gamma globulin level.

The level of gamma globulinemia has not yet been studied as an evolutionary predictive factor. Furthermore, there are disseminated granulomatoses sharing common characteristics with sarcoidosis, associated with Common Variable Immunodeficiency deficit (DICV) type Primary Immunodeficiency syndrome (DIP), thus occurring in hypogammaglobulinemic patients.

Enrollment

78 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients newly diagnosed with sarcoidosis

Exclusion criteria

  • Comorbidity responsible for a change in the level of gamma globulin
  • Other etiology of granulomatosis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems